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Aconite is a potentially toxic root from which herbal
preparations are used to treat common somatic ailments
from headache to heartburn in the Southeast Asian popula-
tion. Lack of awareness of aconite root use in the growing
Hmong population in the United States (US) poses a
potential for loss of life. We present a case of acute aconitine
poisoning in a middle-aged Hmong man in whom (1) a
broad spectrum of electrocardiographic changes and dys-
rhythmias manifested, and (2) critical illness and shock
developed, requiring aggressive life support to prevent loss
of life.Case report
A 62-year-old Hmong man presented to the local emergency
room with complaints of sudden-onset chest pain, dizziness,
and palpitations. Little other history was obtainable owing to
language barrier. The patient appeared in mild distress,
exhibiting generalized weakness. Initial vital signs demon-
strated hypotension and tachycardia with systolic blood
pressure 60–80 mm Hg and heart rate 150–220 beats per
minute. His initial electrocardiogram (ECG) (Figure 1, top)
demonstrated sinus rhythm with low-amplitude P waves and
junctional rhythm conducting with narrow QRS complex,
followed by ventricular ectopics or couplets with right
bundle branch block (RBBB) morphology and left axis
deviation suggestive of left posterior fascicular origin.
Diffuse ST-segment depression was present and the QT
interval was prolonged. Ventricular ectopics occurred during
the terminal phase of the T wave.KEYWORDS Aconite; Aconitine; Conduction disturbance; Ventricular tachy-
cardia; Long QT; Shock; Hmong
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).Initial blood tests revealed hypokalemia (2.9 mmol/L) and
acidosis (pH 7.21) with increased anion gap (17) and
elevated lactate levels (9.7 mmol/L). Troponin T (o0.01
ng/mL) and digoxin levels (0.1 ng/mL) were not elevated.
Intravenous saline was administered. Bedside echocardiog-
raphy demonstrated hyperdynamic left ventricular function
with no regional wall motion abnormalities and no evidence
of pericardial effusion. There were no ﬁndings of Takotsubo
cardiomyopathy. Concern for coronary ischemia and lactic
acidosis prompted urgent coronary angiography, which
demonstrated nonobstructive coronary atherosclerosis with
slow coronary ﬂow. Ventriculography conﬁrmed echocar-
diographic ﬁndings, demonstrating hyperdynamic left ven-
tricular function with no wall motion abnormalities.
Vasodilatory shock was diagnosed. Poor response to
ﬂuids necessitated hemodynamic support with intravenous
pressors and intraaortic balloon pump. The patient was
intubated for impending respiratory failure. Blood cultures
were drawn and empiric antibiotics initiated.
Incessant dysrhythmias continued, including progressive
atrioventricular (AV) conduction delay, left axis deviation in
beats conducting with variable QRS morphologies including
left bundle branch block (LBBB), RBBB ventricular ectopy,
nonsustained monomorphic ventricular tachycardia (VT)
(Figure 1, bottom), sustained monomorphic VT (Figure 2,
top), and bidirectional VT characterized by RBBB morphol-
ogy and alternating QRS axis (Figure 2, bottom). Ventricular
ectopy and sustained arrhythmias persisted despite treatment
with intravenous amiodarone. Cardioversion restored sinus
rhythm but with generally little impact on hemodynamics
and with continued recurrence of dysrhythmias. Hence,
further cardioversion was avoided. Empiric use of hemody-
namic dialysis was considered but was deferred because of
ongoing hemodynamic instability.
English-speaking family members were eventually found
and presented to provide additional history. The patient has a
history of “heartburn” but was not taking any prescription
medications. He had been in his usual health on the day of
presentation. Later he developed his usual heartburnpen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 Narrow QRS complex beat or tachycardia is not
diagnostic of supraventricular origin. In particular,
narrow QRS complexes can arise from the ventricle
in close proximity to the His-Purkinje system that
activates right and left ventricular muscle in a
balanced manner, or owing to ventricular ectopy
occurring ipsilateral to bundle branch block and
simultaneous with intrinsic conduction.
 Ventricular ectopy and ventricular tachycardia are
not always the cause of hemodynamic collapse.
Rather, as seen in this case, ventricular arrhythmias
can be a manifestation of broader physiologic
derangement.
 Herbal and “natural” remedies have the potential
to cause lethal physiologic derangement and must
be considered in the differential when traditional
or more common medical etiologies are excluded.
Heart Rhythm Case Reports, Vol 2, No 5, September 2016416symptom and ingested an herbal decoction made from
boiling various herbs and roots. His symptoms did not
improve over an hour and he repeated the elixir 3–4 times.
Over the next half-hour, he developed chest pain, dizziness,
and generalized weakness with severe nausea, vomiting, and
abdominal pain. The family conﬁrmed use of aconite root.
Serum aconitine level was not obtained, owing to the late
discovery of this information.
The patient improved both hemodynamically and electri-
cally, and supportive care was weaned successfully over the
next 48 hours. Ventricular ectopy and VT resolved and the
rhythm transitioned through AV block with junctional broad
and narrow escape rhythm (Figure 3, top) back to sinus
rhythm with intact conduction and normal PR and QRS
intervals with nonspeciﬁc T-wave abnormalities (Figure 3,
bottom). The patient was discharged uneventfully and
counseled against aconite root use. In follow-up, the patient
has not had a recurrence of dizziness or weakness. He does
still use aconite root, but only in limited amounts.
Discussion
Aconitine is a toxin found in the Aconitum plant, also known
as “devil’s helmet” or “monkshood” (Aconitum napellus)
and wolfsbane (Aconitum vulparia), known for its toxic
properties. The use of aconite root for medicinal purposes is
common in the Hmong, Asian, and Indian populations to
treat various ailments, including heartburn and headache.1
Raw aconite roots are extremely toxic and must be processed
to reduce the alkaloid content before use. Inadequate
processing or ingestion of higher doses of the decoction of
aconite roots increases the risk of poisoning.2
Pure aconitine has low bioavailability with little varia-
bility in the pharmacokinetic behavior after single or multi-
ple administrations. In contrast, multiple administrations ofprocessed Fuzi extract, the processed lateral roots of Aconi-
tum, could increase the bioavailability of aconitine, which
results in toxicity.3
Cellular mechanisms
Aconitine interacts with the voltage-dependent sodium
channel present on cell membranes of excitable tissues,
including myocardium, striated and smooth muscle, and
neurons, altering membrane depolarization and repolariza-
tion. Aconitine binds with high afﬁnity to the voltage-
sensitive sodium channel in its open state and suppresses
the conformational change to the inactive state,4 delaying
repolarization by prolonging sodium inﬂux and membrane
depolarization. Conformational changes to the channel
induced by aconitine binding shift the activation threshold
of the channel to a more negative potential,2 while the
inactivation curve is shifted toward a more positive potential,
resulting in prolonged opening of the channel that predis-
poses to the development and persistence of triggered
activity.1
At lower concentrations, aconite increases the strength of
muscle ﬁber contraction by increasing acetylcholine release
from nerve endings owing to depolarization. In synaptic
clefts, the released acetylcholine binds to postsynaptic
cholinergic receptors to activate sodium channels, generating
action potential and muscle contraction. At higher concen-
trations, persistence of sodium channels in the open state
results in suppression of action potential transmission and
reduced axonal end-terminus acetylcholine release and
depression of muscle contraction.2
In addition, the powerful increase in late sodium channel
current owing to delayed sodium channel inactivation
promotes conditions for early afterdepolarization develop-
ment by prolonging depolarization, as well as activation of
the sodium-calcium exchanger generating a transient inward
current and development of delayed afterdepolarization;1
thus, aconitine-induced triggered activity is related to
increased late INa.
Electrocardiographic manifestations and possible
underlying mechanisms
Important ECG manifestations observed in this case were
supraventricular abnormalities, including low-amplitude P
waves and sinus bradycardia; AV conduction abnormalities
with conduction prolongation and fascicular and bundle
branch block; repolarization abnormalities with QT prolon-
gation; and ventricular ectopy and nonsustained and sus-
tained VT with monomorphism, as well as bidirectionality
that exhibited sharp, rapid QRS onset with RBBB morphol-
ogy suggesting left fascicular origin.
The binding of aconitine to the sodium channel promoting
persistence of the activated state can explain the ECG
ﬁndings in this patient. The AV interval was observed to
prolong with LBBB, suggesting conduction delay within
and/or below the His bundle.5 Preferential block in the left
system fascicles or proximal block in the left bundle system
Figure 1 Presenting electrocardiogram (ECG) (top) and ECG showing progressive changes in atrioventricular conduction (bottom). Both ECGs also
demonstrate ventricular ectopy.
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respectively, which could be attributable to prolonged
depolarization of the His-Purkinje system owing to persis-
tence of sodium channel activation.
The persistence of the activated states occurs at a more
polarized transmembrane voltage than normal, thereby
facilitating development of triggered activity from early
afterdepolarization and increasing the risk of triggered
ventricular arrhythmias.2,6 Salvos of monomorphic VT and
bidirectional VT were observed, presumably related to this
enhanced triggered activity.
The mechanism of QT prolongation related to persistent
sodium inﬂux, also seen in long QT syndrome 3, has been
described by many investigators, in which delayed inactiva-
tion of the late sodium channel results in prolonged sodium
inﬂux during the action potential plateau, prolonging action
potential duration and QT interval.6 This mechanism likely
explains the QT interval prolongation seen in our patient
during conducted and junctional beats.The sinus P waves were difﬁcult to identify and were
nonexistent to low-amplitude at presentation. P-wave ampli-
tude ﬂuctuated on successive ECGs. In addition, conducted
beats developed a broad LBBB morphology with delayed
and prolonged intrinsicoid deﬂection. After discontinuation
of aconitine and clinical improvement over time, the P waves
appeared, albeit at a slow sinus rate, permitting an escape
rhythm, possibly junctional or fascicular/ventricular origin
with narrower QRS than during LBBB morphology–con-
ducted beats, manifesting as AV dissociation. With complete
clinical resolution, sinus P waves assumed their normal
amplitude and morphology with intact AV conduction and
normal ECG intervals. Atrial and ventricular myocardium is
rich in sodium channels like the His-Purkinje system, and
aconitine-induced abnormalities in membrane sodium regu-
lation can explain the intramyocardial atrial and ventricular
conduction abnormalities observed.
Other cardiovascular effects of aconite include hypotension,
chest pain, palpitations, bradycardia, and sinus tachycardia. The
Figure 2 Development of sustained monomorphic (top) and bidirectional (bottom) ventricular tachycardia.
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to central activation of the ventromedial nucleus of the hypo-
thalamus.2 The latter plays an important role in controlling
autonomic nervous system activity and is associated with
depression of the circulatory system, as seen in our patient
presenting with vasodilatory shock. In addition, aconitine has a
positive inotropic effect, also observed in our patient during
ventriculography, related to prolonged sodium inﬂux during the
action potential owing to persistence of the open state.2
Peripheral nerve manifestations include numbness and
motor weakness.7 Aconitine, mesaconitine, and hypaconi-
tine can all induce strong contractions of the ileum through
acetylcholine release from the postganglionic cholinergic
nerves and cause gastrointestinal symptoms such as nausea,
vomiting, and diarrhea.Diagnosis, management, and clinical course
Aconite poisoning usually appears approximately 20
minutes to 2 hours after oral intake and includes paraesthesia,sweating, and nausea, which is followed by vomiting,
diarrhea, abdominal pain, and then skeletal muscle paralysis.
The diagnosis of aconitine poisoning is made by obtain-
ing history compatible with persistence of the sodium
channel–activated state (ie, cardiac, neuromuscular, and
gastrointestinal manifestations) and suggestion or conﬁrma-
tion of aconite use. Two milligrams of pure aconite or 1 g of
aconite plant may cause death.8 Serum aconitine levels may
be measured as well, but little is known regarding nontoxic
levels. Aconitine poisoning is managed with supportive care.
Atropine can be used to counteract bradycardia. Vasopressor
support and even cardiopulmonary bypass have been used to
maintain perfusion in refractory shock.7,9 Ventricular
arrhythmias are frequently refractory to cardioversion owing
to triggered activity that permits arrhythmia persistence and
are often only minimally responsive to antiarrhythmics;
hence aggressive supportive care is the mainstay.
Following the onset of life-threatening arrhythmia,
including VT/ventricular ﬁbrillation, death may occur as a
result of respiratory paralysis or cardiac arrest. The overall
Figure 3 Resolution of ventricular tachycardia and ventricular ectopy with persistent but improving conduction abnormalities (top) and near-complete
resolution (bottom).
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reported to be 5.5%.Prior cases
There have been very few reported cases of aconite poison-
ing causing ventricular arrhythmias in the US and only 1
other reported case of bidirectional VT in the US.7 Some
cases have been reported in Taiwan and Hong Kong,7,10 with
similar presentation of bidirectional VT after consuming
aconite root. In 1 case the arrhythmia was susceptible to
vagotonic maneuvers, cholinesterase inhibition, and adeno-
sine triphosphate.10 Our case is unusual in that a full
spectrum of bradyarrhythmic, tachyarrhythmic, and hemo-
dynamic consequences manifested in a single patient.
The most common cause of mortality from aconite is
ventricular arrhythmias. Intravenous antiarrhythmic agents
with sodium channel–blocking properties, including amiodar-
one, ﬂecainide, procainamide, and mexiletine,11–13 seem to be
partially effective.4 The mechanism is felt to be related to
suppressing persistence of the sodium channel active state.12The use of percutaneous cardiopulmonary support7 and
cardiopulmonary bypass9 for cardiogenic shock from refrac-
tory VT after aconite ingestion has been reported as well.
Patients usually stabilize within 24–48 hours with excre-
tion of aconitine in the urine. Hence, careful attention must
be paid to maintaining renal perfusion and function. Acti-
vated charcoal can be used acutely to reduce gastric
absorption when patients present within 30–60 minutes of
consumption.
The Hmong population in the US has more than quadrupled
since 1980 and is now estimated at 250,000–300,000. As of
2010, more than 90,000 Hmong live in California, more than
60,000 live in Minnesota, and more than 50,000 Hmong live
in Wisconsin,14 where our case occurred. While the large
majority of Hmong have settled in these 3 states, the Hmong
can be found in every state in the US. Awareness of the role of
aconite as an herbal remedy in their culture, and in particular
this unique constellation of cardiac, neurologic, and gastro-
intestinal manifestations with shock and arrhythmias, may aid
in rapid recognition, diagnosis, and appropriate management of
aconitine toxicity.
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